1. Home
  2. KYN vs IMNM Comparison

KYN vs IMNM Comparison

Compare KYN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kayne Anderson Energy Infrastructure Fund Inc.

KYN

Kayne Anderson Energy Infrastructure Fund Inc.

HOLD

Current Price

$14.35

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.62

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYN
IMNM
Founded
2004
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KYN
IMNM
Price
$14.35
$19.62
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$32.80
AVG Volume (30 Days)
344.2K
1.1M
Earning Date
01-01-0001
03-03-2026
Dividend Yield
8.99%
N/A
EPS Growth
N/A
51.40
EPS
0.71
N/A
Revenue
N/A
$6,941,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,127.34
P/E Ratio
$20.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.82
$5.15
52 Week High
$14.49
$27.65

Technical Indicators

Market Signals
Indicator
KYN
IMNM
Relative Strength Index (RSI) 64.56 36.87
Support Level $12.09 $19.26
Resistance Level $14.45 $22.57
Average True Range (ATR) 0.25 1.05
MACD -0.01 -0.04
Stochastic Oscillator 79.86 1.41

Price Performance

Historical Comparison
KYN
IMNM

About KYN Kayne Anderson Energy Infrastructure Fund Inc.

Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: